RecruitingNCT06821243

Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention

Multidimensional Assessment of Virus-associated Head and Neck Cancer Patients for the Discovery of Predictive Biomarkers to Guide Clinical Intervention


Sponsor

Regina Elena Cancer Institute

Enrollment

40 participants

Start Date

Jul 24, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective pilot study, non-interventional, of a biological/radiological nature, which involves the collection of tissue samples, and blood from patients suffering from squamous cell carcinoma of the oropharynx OPSCC for detection of HPV-DNA/RNA and immuno-phenotypic analysis of T cells, study of extracellular vesicles, and dosages of cytokines and chemokines involved in the immune response


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects tissue and clinical data from patients with HPV-related throat cancer (oropharyngeal squamous cell carcinoma) who are having surgery, to search for biological markers that can help predict treatment outcomes and guide decisions. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with squamous cell carcinoma of the oropharynx (throat/tonsil area) - You are scheduled for curative surgery - Your overall health status is adequate (ECOG 0-2) **You may NOT be eligible if...** - Your cancer has already spread to distant organs (metastases) - You have had a previous head and neck cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCS National Cancer Institute "Regina Elena"

Rome, Rome, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06821243


Related Trials